thymidine has been researched along with Cancer of ILEUM in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faessel, HM | 1 |
| Slocum, HK | 1 |
| Rustum, YM | 1 |
| Greco, WR | 1 |
| Wilson, JW | 1 |
| Potten, CS | 1 |
2 other studies available for thymidine and Cancer of ILEUM
| Article | Year |
|---|---|
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplas | 2003 |
The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Apoptosis; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p2 | 2000 |